Vilaprisan (BAY 1002670) + Vilaprisan Placebo + Microgynon + Microgynon Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
30
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Clinical Trial ,Phase I
Conditions
Clinical Trial ,Phase I
Trial Timeline
Jul 17, 2017 → Jan 23, 2019
NCT ID
NCT03210246About Vilaprisan (BAY 1002670) + Vilaprisan Placebo + Microgynon + Microgynon Placebo
Vilaprisan (BAY 1002670) + Vilaprisan Placebo + Microgynon + Microgynon Placebo is a phase 1 stage product being developed by Bayer for Clinical Trial ,Phase I. The current trial status is completed. This product is registered under clinical trial identifier NCT03210246. Target conditions include Clinical Trial ,Phase I.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03210246 | Phase 1 | Completed |
Competing Products
20 competing products in Clinical Trial ,Phase I